共同靶向 VEGFR2 和 PD-L1 可促进胸膜间皮瘤的生存和血管正常化
Co-targeting of VEGFR2 and PD-L1 promotes survival and vasculature normalization in pleural mesothelioma.
52.5分
★★★☆☆
站内排序·非疗效
ALL SOURCES
Co-targeting of VEGFR2 and PD-L1 promotes survival and vasculature normalization in pleural mesothelioma.
αVEGFR2-MICA fusion antibodies enhance immunotherapy effect and synergize with PD-1 blockade.
共 2 条
MEMBER ACCOUNT
登录成功会直接打开下一页。